Our experts attending
Dedicated professionals committed to clinical excellence.
Meet Southern Star Research at BIO-Europe 2026
BIO-Europe brings together biotechnology and pharmaceutical leaders, investors and partners from across the global life sciences ecosystem. Alongside its established partnering focus, this year’s expanded program includes a Clinical Strategy Track covering global trial strategies, regulatory navigation, CRO partnerships and operational efficiency.
If your organisation is advancing a therapeutic candidate and planning the next stage of clinical development, we look forward to connecting with you in Cologne.
Clinical Strategy Across Global Markets
Clinical development is rarely a question of selecting a country or CRO in isolation.
The right approach depends on what the program needs to demonstrate next, whether that is establishing early safety, generating proof-of-concept data, reaching specific patient populations or preparing for a future regulatory, funding or partnering milestone.
Australia and the broader Asia-Pacific region can play an important role within that strategy. Australia offers an established environment for early-phase development, while APAC provides access to experienced sites, diverse patient populations and opportunities for multi-country studies.
Southern Star Research works with biotech teams to determine how these markets can support wider development objectives, considering regulatory requirements, operational feasibility, patient access and future global milestones from the outset.
Why Sponsors Choose Southern Star Research
As an independent, mid-sized CRO with deep experience across Australia and the broader Asia-Pacific region, we offer:
- Strong experience in complex, mechanism-driven trials
- Regulatory insight across the FDA, EMA, PMDA and Health Canada
- Established site networks and patient access across APAC
- Hands-on operational support and senior-level oversight
- A delivery model that balances speed, cost efficiency and data quality
Our focus is to help biotech teams generate high-quality clinical evidence that supports confident decisions about the next stage of development.
Connect With Us at BIO-Europe 2026
Dr. David Lloyd, Director and Founder, and Joe Cox, Business Development Manager, will be attending BIO-Europe 2026 in Cologne.
If your team is considering Australia or Asia-Pacific as part of an upcoming clinical program, evaluating its global trial strategy or preparing for the next stage of development, we would welcome the opportunity to connect.
Book a meeting to discuss your clinical development plans.